HeXun Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
HeXun Biosciences has a total shareholder equity of NT$550.6M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$613.0M and NT$62.3M respectively. HeXun Biosciences's EBIT is NT$116.3M making its interest coverage ratio -54.6. It has cash and short-term investments of NT$277.8M.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -54.6x |
| Cash | NT$277.84m |
| Equity | NT$550.63m |
| Total liabilities | NT$62.35m |
| Total assets | NT$612.97m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6986's short term assets (NT$391.5M) exceed its short term liabilities (NT$30.9M).
Long Term Liabilities: 6986's short term assets (NT$391.5M) exceed its long term liabilities (NT$31.5M).
Debt to Equity History and Analysis
Debt Level: 6986 is debt free.
Reducing Debt: 6986 had no debt 5 years ago.
Debt Coverage: 6986 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6986 has no debt, therefore coverage of interest payments is not a concern.